RadioLogics has completed its AI mammography trial at Pakistan Institute of Medical Sciences (PIMS) in Islamabad, marking another milestone in the adoption of artificial intelligence within Pakistan’s healthcare sector. Conducted at one of the country’s leading public healthcare institutions, the initiative focused on evaluating how AI technology can assist radiologists during mammography procedures while supporting more efficient diagnostic workflows. The trial reflects growing interest in the practical use of artificial intelligence across medical imaging, where healthcare providers are exploring digital technologies that can complement clinical expertise, improve operational efficiency and strengthen patient care. By carrying out the evaluation in a real clinical environment, RadioLogics gained the opportunity to assess how its AI solution performs under everyday healthcare conditions while working alongside medical professionals.
As a major public sector healthcare institution, Pakistan Institute of Medical Sciences (PIMS) plays an important role in delivering diagnostic and medical services to patients from across Pakistan. The completion of the AI mammography trial represents a meaningful step in examining how artificial intelligence can support healthcare professionals during breast imaging procedures without replacing clinical judgment. Instead, the technology is designed to provide additional analytical support that may assist radiologists in reviewing mammography images more efficiently while contributing to improved workflow management. The collaboration also provided valuable insights into how AI solutions can be integrated into public healthcare settings, where technology adoption must align with clinical practices, patient requirements and institutional standards.
The project enabled RadioLogics to evaluate its AI technology under real world conditions while strengthening collaboration between healthcare professionals and technology innovators. The experience allowed both clinical experts and AI specialists to better understand operational requirements, identify opportunities for workflow enhancement and assess how intelligent imaging solutions can be incorporated into existing healthcare environments. RadioLogics acknowledged the support of Prof. Dr. Ayesha Isani Majeed, Head of the Department of Radiology and Director of the Federal Breast Cancer Screening Centre at PIMS, for her role in supporting the initiative and helping facilitate collaboration between the healthcare institution and the technology provider. Such partnerships continue to play an important role in ensuring that emerging healthcare technologies are evaluated with direct involvement from experienced medical professionals.
RadioLogics stated that progress in healthcare artificial intelligence depends on responsible evaluation, close clinical collaboration and a clear understanding of the needs of healthcare professionals. The company emphasised that conducting trials in practical healthcare settings helps generate meaningful insights into how AI can complement existing diagnostic processes while supporting radiologists in their daily work. The completion of the PIMS trial contributes to ongoing efforts to explore the role of artificial intelligence in radiology across Pakistan and demonstrates continued engagement between technology developers and healthcare institutions. As digital health technologies continue to evolve, initiatives of this nature provide opportunities to assess innovative solutions in clinical environments while encouraging collaboration that supports more efficient medical imaging practices and broader healthcare innovation across the country.
Follow the SPIN IDG WhatsApp Channel for updates across the Smart Pakistan Insights Network covering all of Pakistan’s technology ecosystem.
